Patients with Autoimmune Thyroid Diseases Have Higher Prevalence of Positive Antiphospholipid Antibodies: A Systematic Review and Meta-Analysis

Introduction. Autoimmune thyroid diseases (AITDs) and antiphospholipid syndrome (APS) are commonly seen in childbearing-age women and can lead to recurrent miscarriages. Studies with a relatively small sample size were conducted and concluded inconsistent results on the relationship between AITDs an...

Full description

Saved in:
Bibliographic Details
Main Authors: Difei Lu, Zhibo Song, Ying Gao, Junqing Zhang, Xiaohui Guo
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2022/8271951
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850172828038463488
author Difei Lu
Zhibo Song
Ying Gao
Junqing Zhang
Xiaohui Guo
author_facet Difei Lu
Zhibo Song
Ying Gao
Junqing Zhang
Xiaohui Guo
author_sort Difei Lu
collection DOAJ
description Introduction. Autoimmune thyroid diseases (AITDs) and antiphospholipid syndrome (APS) are commonly seen in childbearing-age women and can lead to recurrent miscarriages. Studies with a relatively small sample size were conducted and concluded inconsistent results on the relationship between AITDs and APS or the presence of antiphospholipid (aPL) antibodies. This meta-analysis aimed to provide evidence on the possible association between AITDs and APL using primary data from all relevant studies. Methods. Literature databases including PubMed, Embase, and Cochrane were searched from the time when the databases were established to March 2022. A total of 7 studies that met all inclusion criteria were selected in this meta-analysis, with 475 AITD patients and 764 healthy controls. After data extraction, the pooled odds ratio (OR) and the 95% confidence interval (95% CI) were calculated. Results. The risk of positive APL in AITD patients was approximately 3 folds higher in AITD patients compared with those in healthy controls (OR 3.41, 95% CI 2.29–5.08, p<0.001). There was no significant association between the risk of Graves’ disease (GD) and positive APL (OR 9.3, 95% CI 0.10–824.73, p=0.33). The risk of positive APL in patients with Hashimoto’s thyroiditis (HT) increased over 2 folds compared with healthy controls (OR 3.35, 95% CI 1.55–7.23, p=0.002). Conclusions. The result of this meta-analysis proved that the presence of APL was significantly increased in patients with AITD compared with healthy individuals, especially in patients with Hashimoto’s thyroiditis.
format Article
id doaj-art-d4c76cd7666e4b7caed63d351ec657ea
institution OA Journals
issn 1687-8345
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-d4c76cd7666e4b7caed63d351ec657ea2025-08-20T02:19:58ZengWileyInternational Journal of Endocrinology1687-83452022-01-01202210.1155/2022/8271951Patients with Autoimmune Thyroid Diseases Have Higher Prevalence of Positive Antiphospholipid Antibodies: A Systematic Review and Meta-AnalysisDifei Lu0Zhibo Song1Ying Gao2Junqing Zhang3Xiaohui Guo4Department of EndocrinologyDepartment of Rheumatology and Clinical ImmunologyDepartment of EndocrinologyDepartment of EndocrinologyDepartment of EndocrinologyIntroduction. Autoimmune thyroid diseases (AITDs) and antiphospholipid syndrome (APS) are commonly seen in childbearing-age women and can lead to recurrent miscarriages. Studies with a relatively small sample size were conducted and concluded inconsistent results on the relationship between AITDs and APS or the presence of antiphospholipid (aPL) antibodies. This meta-analysis aimed to provide evidence on the possible association between AITDs and APL using primary data from all relevant studies. Methods. Literature databases including PubMed, Embase, and Cochrane were searched from the time when the databases were established to March 2022. A total of 7 studies that met all inclusion criteria were selected in this meta-analysis, with 475 AITD patients and 764 healthy controls. After data extraction, the pooled odds ratio (OR) and the 95% confidence interval (95% CI) were calculated. Results. The risk of positive APL in AITD patients was approximately 3 folds higher in AITD patients compared with those in healthy controls (OR 3.41, 95% CI 2.29–5.08, p<0.001). There was no significant association between the risk of Graves’ disease (GD) and positive APL (OR 9.3, 95% CI 0.10–824.73, p=0.33). The risk of positive APL in patients with Hashimoto’s thyroiditis (HT) increased over 2 folds compared with healthy controls (OR 3.35, 95% CI 1.55–7.23, p=0.002). Conclusions. The result of this meta-analysis proved that the presence of APL was significantly increased in patients with AITD compared with healthy individuals, especially in patients with Hashimoto’s thyroiditis.http://dx.doi.org/10.1155/2022/8271951
spellingShingle Difei Lu
Zhibo Song
Ying Gao
Junqing Zhang
Xiaohui Guo
Patients with Autoimmune Thyroid Diseases Have Higher Prevalence of Positive Antiphospholipid Antibodies: A Systematic Review and Meta-Analysis
International Journal of Endocrinology
title Patients with Autoimmune Thyroid Diseases Have Higher Prevalence of Positive Antiphospholipid Antibodies: A Systematic Review and Meta-Analysis
title_full Patients with Autoimmune Thyroid Diseases Have Higher Prevalence of Positive Antiphospholipid Antibodies: A Systematic Review and Meta-Analysis
title_fullStr Patients with Autoimmune Thyroid Diseases Have Higher Prevalence of Positive Antiphospholipid Antibodies: A Systematic Review and Meta-Analysis
title_full_unstemmed Patients with Autoimmune Thyroid Diseases Have Higher Prevalence of Positive Antiphospholipid Antibodies: A Systematic Review and Meta-Analysis
title_short Patients with Autoimmune Thyroid Diseases Have Higher Prevalence of Positive Antiphospholipid Antibodies: A Systematic Review and Meta-Analysis
title_sort patients with autoimmune thyroid diseases have higher prevalence of positive antiphospholipid antibodies a systematic review and meta analysis
url http://dx.doi.org/10.1155/2022/8271951
work_keys_str_mv AT difeilu patientswithautoimmunethyroiddiseaseshavehigherprevalenceofpositiveantiphospholipidantibodiesasystematicreviewandmetaanalysis
AT zhibosong patientswithautoimmunethyroiddiseaseshavehigherprevalenceofpositiveantiphospholipidantibodiesasystematicreviewandmetaanalysis
AT yinggao patientswithautoimmunethyroiddiseaseshavehigherprevalenceofpositiveantiphospholipidantibodiesasystematicreviewandmetaanalysis
AT junqingzhang patientswithautoimmunethyroiddiseaseshavehigherprevalenceofpositiveantiphospholipidantibodiesasystematicreviewandmetaanalysis
AT xiaohuiguo patientswithautoimmunethyroiddiseaseshavehigherprevalenceofpositiveantiphospholipidantibodiesasystematicreviewandmetaanalysis